Exact Mass: 766.2261

Exact Mass Matches: 766.2261

Found 29 metabolites which its exact mass value is equals to given mass value 766.2261, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Iryantherin F

C43H42O13 (766.2625)

[(2R,3S,4S,5R,6S)-6-[4-[6-[4-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-methoxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate

[(2R,3S,4S,5R,6S)-6-[4-[6-[4-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-methoxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate

C36H46O18 (766.2684)

4,4-Bissolorinic acid

C42H38O14 (766.2261)

rossicaside G|trans-p-coumaryl alcohol-O-beta-D-glucopyranosyl(1?4)-alpha-L-rhamnopyranosyl(1?3)(4-O-trans-p-coumaryl)-beta-D-glucopyranoside

C36H46O18 (766.2684)

rossicaside H|trans-p-coumaryl alcohol-O-beta-D-glucopyranosyl(1?4)-alpha-L-rhamnopyranosyl(1?3)(6-O-trans-p-coumaryl)-beta-D-glucopyranoside

C36H46O18 (766.2684)

(R)-triquetrumone D|5,2,4,5,2,4-hexahydroxy-3,3-dimethoxy-[6,6-dimethylpyrano(2,3:7,8)]-[6,6-dimethylpyrano(2,3:7,8)]-3,3-biisoflavanone

C42H38O14 (766.2261)

[(2R,3S,4S,5R,6S)-6-[4-[6-[4-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-methoxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate_major

C36H46O18 (766.2684)

[(2R,3S,4S,5R,6S)-6-[4-[6-[4-[(2S,3R,4S,5S,6R)-6-(acetyloxymethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-methoxyphenyl]-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan-3-yl]-2-methoxyphenoxy]-3,4,5-trihydroxyoxan-2-yl]methyl acetate_1.4\\%

C36H46O18 (766.2684)

4-(4-{4-[(6-O-Acetyl-?-D-glucopyranosyl)oxy]-3-methoxyphenyl}tetrahydro-1H,3H-furo[3,4-c]furan-1-yl)-2-methoxyphenyl 6-O-acetyl-?-D-glucopyranoside

C36H46O18 (766.2684)

Esomeprazole magnesium

C34H42MgN6O9S2 (766.2305)

(BICYCLO[2.2.1]HEPTA-2,5-DIENE)[1,4-BIS(DIPHENYLPHOSPHINO)BUTANE]RHODIUM(I) TETRAFLUOROBORATE

C38H42BF4OP2Rh (766.1795)

Esomeprazole magnesium hydrate

C34H42MgN6O9S2 (766.2305)

C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors

{diazenediylbis[(4,1-phenylene)(6-methyl-1,3-benzothiazole-2,5-diyl)methylenesulfanediyl]}bis[(dimethylamino)-N,N-dimethylmethaniminium]

C40H46N8S4+2 (766.2728)

PIP 24:6

C33H52O16P2 (766.273)

3-(3,5-dihydroxy-4-methoxyphenyl)-3-[3-(3,5-dihydroxy-4-methoxyphenyl)-5-hydroxy-8,8-dimethyl-4-oxo-2h-pyrano[2,3-f]chromen-3-yl]-5-hydroxy-8,8-dimethyl-2h-pyrano[2,3-f]chromen-4-one

C42H38O14 (766.2261)

1-[2-({2,6-dihydroxy-4-methoxy-3-[3-(4-methoxyphenyl)propanoyl]phenyl}(2,4,5-trihydroxyphenyl)methyl)-4-hydroxy-6-methoxy-2,3-dihydro-1-benzofuran-5-yl]-3-(4-methoxyphenyl)propan-1-one

C43H42O13 (766.2625)

4'-hydroxy-4-(4-hydroxyphenyl)-2,5,6-tris({[(2z)-3-[(2r,3s)-3-methyloxiran-2-yl]prop-2-enoyl]oxy})-[1,1'-biphenyl]-3-yl (2z)-3-[(2r,3s)-3-methyloxiran-2-yl]prop-2-enoate

C42H38O14 (766.2261)

4'-hydroxy-4-(4-hydroxyphenyl)-2,5,6-tris({[(2z)-3-[(2s,3s)-3-methyloxiran-2-yl]prop-2-enoyl]oxy})-[1,1'-biphenyl]-3-yl (2z)-3-[(2s,3s)-3-methyloxiran-2-yl]prop-2-enoate

C42H38O14 (766.2261)

1-[(2s)-2-[(r)-{2,6-dihydroxy-4-methoxy-3-[3-(4-methoxyphenyl)propanoyl]phenyl}(2,4,5-trihydroxyphenyl)methyl]-4-hydroxy-6-methoxy-2,3-dihydro-1-benzofuran-5-yl]-3-(4-methoxyphenyl)propan-1-one

C43H42O13 (766.2625)

(2s,3as,6r,7as)-1-[(2r,3s)-2-{[(2r)-3-(3-bromo-5-chloro-4-hydroxyphenyl)-1,2-dihydroxypropylidene]amino}-3-methylpentanoyl]-n-(4-carbamimidamidobutyl)-6-(sulfooxy)-octahydroindole-2-carboximidic acid

C29H44BrClN6O9S (766.1762)

4'-hydroxy-4-(4-hydroxyphenyl)-5-{[(2z)-3-[(2r,3r)-3-methyloxiran-2-yl]prop-2-enoyl]oxy}-2,6-bis({[(2z)-3-[(2s,3s)-3-methyloxiran-2-yl]prop-2-enoyl]oxy})-[1,1'-biphenyl]-3-yl (2z)-3-[(2s,3s)-3-methyloxiran-2-yl]prop-2-enoate

4'-hydroxy-4-(4-hydroxyphenyl)-5-{[(2z)-3-[(2r,3r)-3-methyloxiran-2-yl]prop-2-enoyl]oxy}-2,6-bis({[(2z)-3-[(2s,3s)-3-methyloxiran-2-yl]prop-2-enoyl]oxy})-[1,1'-biphenyl]-3-yl (2z)-3-[(2s,3s)-3-methyloxiran-2-yl]prop-2-enoate

C42H38O14 (766.2261)

2-(4a-hydroxy-8-oxo-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h-pyrano[3,4-c]pyran-4-yl)-2-hydroxyethyl 6-hydroxy-7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

2-(4a-hydroxy-8-oxo-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,4h,5h,6h-pyrano[3,4-c]pyran-4-yl)-2-hydroxyethyl 6-hydroxy-7-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-4-carboxylate

C32H46O21 (766.2531)

1-(2-{[3-(3-bromo-5-chloro-4-hydroxyphenyl)-1,2-dihydroxypropylidene]amino}-3-methylpentanoyl)-n-(4-carbamimidamidobutyl)-6-(sulfooxy)-octahydroindole-2-carboximidic acid

C29H44BrClN6O9S (766.1762)

(9z)-n-(3-{2,6-dibromo-4-[(2z)-2-(hydroxyimino)-2-{[2-(2-imino-1,3-dihydroimidazol-4-yl)ethyl]-c-hydroxycarbonimidoyl}ethyl]phenoxy}propyl)-15-methylhexadec-9-enimidic acid

C34H52Br2N6O4 (766.2417)

(3r)-3-(3,5-dihydroxy-4-methoxyphenyl)-3-[(3r)-3-(3,5-dihydroxy-4-methoxyphenyl)-5-hydroxy-8,8-dimethyl-4-oxo-2h-pyrano[2,3-f]chromen-3-yl]-5-hydroxy-8,8-dimethyl-2h-pyrano[2,3-f]chromen-4-one

C42H38O14 (766.2261)

4'-hydroxy-4-(4-hydroxyphenyl)-2,5,6-tris({[3-(3-methyloxiran-2-yl)prop-2-enoyl]oxy})-[1,1'-biphenyl]-3-yl 3-(3-methyloxiran-2-yl)prop-2-enoate

C42H38O14 (766.2261)